ArticleAmerican journal of translational research2026

Comparison of two omalizumab dose-reduction strategies in patients with chronic spontaneous urticaria during the control phase: standard dose maintenance therapy versus extended interval dose reduction.

Li Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.